Russian opposition leader jailed over anti-war social media posts
NewsFeedRussian opposition politician Maxim Kruglov has been sentenced to seven years in prison over two…
NewsFeedRussian opposition politician Maxim Kruglov has been sentenced to seven years in prison over two…
राम मंदिर में चढ़ावा चोरी विवाद के बीच सीएम योगी शुक्रवार को पहली बार अयोध्या…
They won bipartisan allies from Bernie Sanders to Rand Paul, and helped create a billion-dollar industry out of kratom, which has pain-relieving effects they said could help fight the opioid epidemic as a far safer, natural alternative to pills.
Now, many of those same pro-kratom activists are calling for a ban on products containing concentrates of one of kratom’s active components: 7-hydroxymitragynine, or 7-OH, an ultra-potent extract with opioid-like effects. And it’s causing major friction amongst consumers, sellers, and advocates of both substances.
“This is a chemically manipulated, full-blown opioid that is now in the marketplace,” claims Mac Haddow, the senior public policy fellow at the American Kratom Association, a kratom industry lobby group. “They masquerade as kratom products.”
The proliferation of 7-OH in gummies, capsules, and shots with brand names like Magic 7OH, 7 O’Heaven, and Pure OHMS across thousands of gas stations and corner stores over the past few years has caused increasing consternation. Consumers of 7-OH have spoken of its excruciating withdrawal symptoms, and there have been reports of polydrug overdoses involving 7-OH and other substances. Some are now entering rehab to overcome their dependency, while others are self-detoxing based on advice from Redditors.
The kratom community fears that 7-OH’s bad reputation could drag the entire kratom industry into a regulatory quagmire. But the 7-OH industry has organized against the potential prohibition, claiming 7-OH is kratom, despite only appearing in trace amounts within the leaves of the kratom plant, and that its benefits as an analgesic outweigh its potential harms.
Anti-7-OH directives from the federal government have exacerbated tensions between the two sides.
Last July, US Health and Human Services secretary Robert F. Kennedy Jr. described the 7-OH industry as “sinister” at a press conference where FDA commissioner Marty Makary called for the DEA to categorize the drug as Schedule I—the most restrictive class of banned substances. Speaking from the Oval Office on May 11, President Donald Trump publicly endorsed “natural 7-OH,” in confusing remarks which appeared to refer to kratom. On top of all that, it appears that both RFK Jr. and Department of Homeland Security secretary Markwayne Mullin—who is also pushing for a 7-OH crackdown—have strong ties to a kratom lobbyist (and convicted criminal) behind a notorious kratom drinks company.
Proponents of 7-OH see the substance and the plant it’s derived from as inexorably linked. In April 2025 testimony to Colorado legislators debating how to regulate kratom and 7-OH, Michele Ross, the chief scientific adviser to the 7-OH advocacy group 7-HOPE Alliance, wrote, “To say 7-OH is not kratom is to say caffeine is not coffee or THC is not cannabis. It simply does not make sense.”
But as opposed to coffee, cannabis, and kratom—which have been consumed for centuries if not thousands of years—7-OH does not have a long history of human use. It’s only been on the market for a few years.
Many of the products that are labeled 7-OH contain little-understood compounds with unknown biological effects in animals or humans, says Chris McCurdy, a leading kratom researcher and director of the University of Florida’s translational drug development core. “So, these products, while represented as ‘clean’ are anything but.”
Meanwhile, a dozen states, from California to Vermont, according to reports, have already moved ahead of federal scheduling with their own 7-OH bans. Seven of those states have also banned kratom, although Rhode Island recently overturned its prohibition.
A decade ago, kratom advocates fought a surprisingly successful campaign against a proposed Drug Enforcement Administration ban that claimed the obscure Southeast Asian plant posed “an imminent hazard to public safety.”
They won bipartisan allies from Bernie Sanders to Rand Paul, and helped create a billion-dollar industry out of kratom, which has pain-relieving effects they said could help fight the opioid epidemic as a far safer, natural alternative to pills.
Now, many of those same pro-kratom activists are calling for a ban on products containing concentrates of one of kratom’s active components: 7-hydroxymitragynine, or 7-OH, an ultra-potent extract with opioid-like effects. And it’s causing major friction amongst consumers, sellers, and advocates of both substances.
“This is a chemically manipulated, full-blown opioid that is now in the marketplace,” claims Mac Haddow, the senior public policy fellow at the American Kratom Association, a kratom industry lobby group. “They masquerade as kratom products.”
The proliferation of 7-OH in gummies, capsules, and shots with brand names like Magic 7OH, 7 O’Heaven, and Pure OHMS across thousands of gas stations and corner stores over the past few years has caused increasing consternation. Consumers of 7-OH have spoken of its excruciating withdrawal symptoms, and there have been reports of polydrug overdoses involving 7-OH and other substances. Some are now entering rehab to overcome their dependency, while others are self-detoxing based on advice from Redditors.
The kratom community fears that 7-OH’s bad reputation could drag the entire kratom industry into a regulatory quagmire. But the 7-OH industry has organized against the potential prohibition, claiming 7-OH is kratom, despite only appearing in trace amounts within the leaves of the kratom plant, and that its benefits as an analgesic outweigh its potential harms.
Anti-7-OH directives from the federal government have exacerbated tensions between the two sides.
Last July, US Health and Human Services secretary Robert F. Kennedy Jr. described the 7-OH industry as “sinister” at a press conference where FDA commissioner Marty Makary called for the DEA to categorize the drug as Schedule I—the most restrictive class of banned substances. Speaking from the Oval Office on May 11, President Donald Trump publicly endorsed “natural 7-OH,” in confusing remarks which appeared to refer to kratom. On top of all that, it appears that both RFK Jr. and Department of Homeland Security secretary Markwayne Mullin—who is also pushing for a 7-OH crackdown—have strong ties to a kratom lobbyist (and convicted criminal) behind a notorious kratom drinks company.
Proponents of 7-OH see the substance and the plant it’s derived from as inexorably linked. In April 2025 testimony to Colorado legislators debating how to regulate kratom and 7-OH, Michele Ross, the chief scientific adviser to the 7-OH advocacy group 7-HOPE Alliance, wrote, “To say 7-OH is not kratom is to say caffeine is not coffee or THC is not cannabis. It simply does not make sense.”
But as opposed to coffee, cannabis, and kratom—which have been consumed for centuries if not thousands of years—7-OH does not have a long history of human use. It’s only been on the market for a few years.
Many of the products that are labeled 7-OH contain little-understood compounds with unknown biological effects in animals or humans, says Chris McCurdy, a leading kratom researcher and director of the University of Florida’s translational drug development core. “So, these products, while represented as ‘clean’ are anything but.”
Meanwhile, a dozen states, from California to Vermont, according to reports, have already moved ahead of federal scheduling with their own 7-OH bans. Seven of those states have also banned kratom, although Rhode Island recently overturned its prohibition.
A decade ago, kratom advocates fought a surprisingly successful campaign against a proposed Drug Enforcement…
Heidi Montag publicly addressed her husband Spencer Pratt’s Los Angeles mayoral loss. “I couldn’t love…
Shortly after Jassy shared the company’s findings with the government, it made the call to block its use by foreign nationals. Complicating this issue is that many of Anthropic’s researchers are foreign-born, meaning they were barred from accessing their own product.
In a statement, Anthropic disputed the government’s characterization of the issue as a “jailbreak.” It argued that many of the same vulnerabilities could be discovered using other publicly available models, including GPT 5.5. Some security researchers appear to back the company’s interpretation. Katie Moussouris, the founder and CEO of LutaSecurity posted on BlueSky that “I’ve seen the paper. It’s not a jailbreak.” Former Commerce Department official Kate Koren speculated to the WSJ that the White House’s dislike of Anthropic may have influenced the decision.
Anthropic and the Trump administration have been at odds for some time over the company’s refusal to allow its AI to be used for mass surveillance of Americans or to power lethal autonomous weapons. In February, Trump instructed federal agencies to stop using Anthropic’s AI. And just hours later, Secretary of Defense Pete Hegseth designated the company a supply chain risk.
The government and the company seemed to have made amends, and the two had worked together to expand access to Mythos. However, now the two seem destined to clash again.
Shortly after Jassy shared the company’s findings with the government, it made the call to block its use by foreign nationals. Complicating this issue is that many of Anthropic’s researchers are foreign-born, meaning they were barred from accessing their own product.
In a statement, Anthropic disputed the government’s characterization of the issue as a “jailbreak.” It argued that many of the same vulnerabilities could be discovered using other publicly available models, including GPT 5.5. Some security researchers appear to back the company’s interpretation. Katie Moussouris, the founder and CEO of LutaSecurity posted on BlueSky that “I’ve seen the paper. It’s not a jailbreak.” Former Commerce Department official Kate Koren speculated to the WSJ that the White House’s dislike of Anthropic may have influenced the decision.
Anthropic and the Trump administration have been at odds for some time over the company’s refusal to allow its AI to be used for mass surveillance of Americans or to power lethal autonomous weapons. In February, Trump instructed federal agencies to stop using Anthropic’s AI. And just hours later, Secretary of Defense Pete Hegseth designated the company a supply chain risk.
The government and the company seemed to have made amends, and the two had worked together to expand access to Mythos. However, now the two seem destined to clash again.
According to the Wall Street Journal, the export control directive that led to Anthropic cutting off access to Fable 5 and Mythos 5 was triggered in part by cybersecurity research from Amazon and conversations between CEO Andy Jassy and the White House. According to the report, the paper from Amazon claims that, through a series of prompts, it was able to get Fable 5 to serve up information that could be used in cyberattacks. Amazon has yet to respond to a request for comment.
Shortly after Jassy shared the company’s findings with the government, it made the call to block its use by foreign nationals. Complicating this issue is that many of Anthropic’s researchers are foreign-born, meaning they were barred from accessing their own product.
In a statement, Anthropic disputed the government’s characterization of the issue as a “jailbreak.” It argued that many of the same vulnerabilities could be discovered using other publicly available models, including GPT 5.5. Some security researchers appear to back the company’s interpretation. Katie Moussouris, the founder and CEO of LutaSecurity posted on BlueSky that “I’ve seen the paper. It’s not a jailbreak.” Former Commerce Department official Kate Koren speculated to the WSJ that the White House’s dislike of Anthropic may have influenced the decision.
Anthropic and the Trump administration have been at odds for some time over the company’s refusal to allow its AI to be used for mass surveillance of Americans or to power lethal autonomous weapons. In February, Trump instructed federal agencies to stop using Anthropic’s AI. And just hours later, Secretary of Defense Pete Hegseth designated the company a supply chain risk.
The government and the company seemed to have made amends, and the two had worked together to expand access to Mythos. However, now the two seem destined to clash again.
According to the Wall Street Journal, the export control directive that led to Anthropic cutting…
A federal judge has ruled that President Donald Trump‘s name must come off the John…
नटराजन का नामांकन रद होने के बाद कांग्रेस नेता विरोध प्रदर्शन कर रहे हैं। इसी…
It was his first speech in front of parliament as Iraq’s prime minister, and Ali…
As Spencer Pratt’s high-profile race to be the next mayor of Los Angeles comes to…
In 2019, Alex Vindman testified during President Trump’s first impeachment trial–a decision that ended his…